BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

4.750

-0.850 (-15.18%)

At close: Aug 14, 2025, 4:00 PM

4.750

0.00 (0.00%)

After-hours: Aug 14, 2025, 7:14 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Neuroscience and Immuno-oncology Drugs	1.38M	Log In
Neuroscience and Immuno-oncology Drugs Growth	268.00%	Log In

Revenue by Geography

Fiscal year is January - December.